4.700
−39,74%
2025-12-01
Fundamental Analysis
89 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +125.2% | +109.1% | 3 / 3 | +405.4% | +73.30 pp | +125.52 pp | +13.2% | 0.00 | 3.35 | 16,1 | +405,4% | 1,0 | +125,2% | 3.35 | 15.34 | −78,2% |
| Pts | 12 | 12 | 12 | 12 | 12 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 4.700 (close price on 2025-12-01)EPS (TTM): 1.404
Financial charts
1.Revenue & growth
VND bn16,1Q2/26
1.Revenue & growth
VND bn16,1Q2/26
2.Profit & growth
VND bn0,96Q2/26
3.Profit mix (Penman)
VND bn29,6Q2/26
4.Margins & cost structure
%-23.9%Q2/26
5.Returns & cash cycle
% · days-16.1%Q2/26
6.Earnings quality & cash
VND bn-14,8Q2/26
7.Asset structure
VND bn204Q2/26
8.Funding & debt health
VND bn · times204Q2/26
9.Revenue backlog
VND bn6,70Q2/26
10.Valuation
times · %3,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %55Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
108%
averaged over 1 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26